Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests for the early detection of multiple cancers.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk

Description

Urteste S.A. is a biotechnology company specializing in the development of non-invasive diagnostic technologies for early cancer detection. The company's core focus is on creating a method to detect multiple types of cancer from a single urine sample. This approach aims to identify malignancies at their earliest stages, potentially improving patient survival rates. The development pipeline includes diagnostic tests for various cancers, with projects such as a prototype for detecting brain tumors and planned clinical trials for a pancreatic cancer test.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2026-01-02 14:07
Zawiadomienie
Polish 78.3 KB
2026-01-02 14:07
Zawiadomienie o zmianie stanu posiadania akcji Spółki - Content (PL)
Polish 837 bytes
2025-12-30 15:12
Zestawienie zmian
Polish 153.9 KB
2025-12-30 15:12
Statut Spółki
Polish 568.1 KB
2025-12-30 15:12
Rejestracja podwyższenia kapitału zakładowego i zmian w statucie Spółki - Conte…
Polish 3.4 KB
2025-12-23 15:52
Podsumowanie subskrypcji akcji serii G - Content (PL)
Polish 5.9 KB
2025-12-12 11:38
Zawarcie umów objęcia akcji serii G - Content (PL)
Polish 1.8 KB
2025-12-10 10:57
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 1.6 KB
2025-12-04 17:00
Podjęte uchwały
Polish 294.0 KB
2025-12-04 17:00
Treść uchwał podjętych podczas obrad Nadzwyczajnego Walnego Zgromadzenia w dniu…
Polish 657 bytes
2025-11-28 08:18
Raport kwartalny 3Q2025
Polish 1.2 MB
2025-11-07 16:00
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish 178.5 KB
2025-11-07 16:00
Projekty uchwał
Polish 229.9 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish 160.7 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish 156.4 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.